NSG552 / NSG 552 EXAM 2
(2 VERSIONS EXAMS)
Psychopharmacology - Wilkes
Actual Questions and Answers
100% Guarantee Pass
This Exam contains:
(2 Exams)
100% Guarantee Pass.
Multiple-Choice (A–D), For Each Question.
Each Question Includes The Correct Answer
Expert-Verified explanation
,Table of Contents
NSG552 / NSG 552 EXAM 2 VERSION 1 .................... 2
NSG552 / NSG 552 EXAM 2 VERSION 2 .................. 64
NSG552 / NSG 552 EXAM 2 VERSION 1
---
### 1. Why are benzodiazepines contraindicated in PTSD treatment?
Answer: Benzodiazepines are contraindicated because they interfere
with cognitive processes necessary for cognitive-behavioral therapy
(CBT) and carry a high risk of dependence, particularly in patients
with comorbid substance use disorders (SUD).
Explanation: While benzodiazepines may provide short-term relief
for anxiety, their sedative effects can hinder emotional processing
and cognitive functions critical for recovery. This makes them
unsuitable for PTSD treatment, where therapeutic engagement is
vital.
,---
### 2. What medications are FDA-approved to treat PTSD?
Answer: Sertraline and paroxetine are the FDA-approved
medications for treating PTSD.
Explanation: These SSRIs have undergone rigorous clinical testing
demonstrating their efficacy in relieving PTSD symptoms. Their
approval indicates their importance in treatment protocols, offering
relief and improving quality of life for affected individuals.
---
### 3. When would you augment treatment of PTSD with an atypical
antipsychotic?
Answer: Augmentation with an atypical antipsychotic is considered
only in severe cases of PTSD.
Explanation: Atypical antipsychotics may be effective in managing
severe PTSD symptoms, especially when first-line medications fail.
However, they carry more significant side effects and risks, so their
use should be reserved for patients who have not responded to SSRI
treatment.
, ---
### 4. What co-occurring disorder do patients with DID typically
have?
Answer: Patients with Dissociative Identity Disorder (DID) often have
co-occurring Post-Traumatic Stress Disorder (PTSD).
Explanation: The traumatic experiences that lead to DID frequently
overlap with those that cause PTSD. Both disorders can exacerbate
each other, making integrated treatment approaches essential for
effective management.
### 5. What are adjustment disorders?
Answer: Adjustment disorders occur when a person develops
emotional or behavioral symptoms in response to a stressful event
or situation. Symptoms differ from normal bereavement and
typically resolve within 6 months after the stressor's end.
Explanation: Adjustment disorders highlight the challenge some
individuals face in adapting to stressors. Symptoms can include
anxiety, sadness, and difficulty functioning. Recognizing and
(2 VERSIONS EXAMS)
Psychopharmacology - Wilkes
Actual Questions and Answers
100% Guarantee Pass
This Exam contains:
(2 Exams)
100% Guarantee Pass.
Multiple-Choice (A–D), For Each Question.
Each Question Includes The Correct Answer
Expert-Verified explanation
,Table of Contents
NSG552 / NSG 552 EXAM 2 VERSION 1 .................... 2
NSG552 / NSG 552 EXAM 2 VERSION 2 .................. 64
NSG552 / NSG 552 EXAM 2 VERSION 1
---
### 1. Why are benzodiazepines contraindicated in PTSD treatment?
Answer: Benzodiazepines are contraindicated because they interfere
with cognitive processes necessary for cognitive-behavioral therapy
(CBT) and carry a high risk of dependence, particularly in patients
with comorbid substance use disorders (SUD).
Explanation: While benzodiazepines may provide short-term relief
for anxiety, their sedative effects can hinder emotional processing
and cognitive functions critical for recovery. This makes them
unsuitable for PTSD treatment, where therapeutic engagement is
vital.
,---
### 2. What medications are FDA-approved to treat PTSD?
Answer: Sertraline and paroxetine are the FDA-approved
medications for treating PTSD.
Explanation: These SSRIs have undergone rigorous clinical testing
demonstrating their efficacy in relieving PTSD symptoms. Their
approval indicates their importance in treatment protocols, offering
relief and improving quality of life for affected individuals.
---
### 3. When would you augment treatment of PTSD with an atypical
antipsychotic?
Answer: Augmentation with an atypical antipsychotic is considered
only in severe cases of PTSD.
Explanation: Atypical antipsychotics may be effective in managing
severe PTSD symptoms, especially when first-line medications fail.
However, they carry more significant side effects and risks, so their
use should be reserved for patients who have not responded to SSRI
treatment.
, ---
### 4. What co-occurring disorder do patients with DID typically
have?
Answer: Patients with Dissociative Identity Disorder (DID) often have
co-occurring Post-Traumatic Stress Disorder (PTSD).
Explanation: The traumatic experiences that lead to DID frequently
overlap with those that cause PTSD. Both disorders can exacerbate
each other, making integrated treatment approaches essential for
effective management.
### 5. What are adjustment disorders?
Answer: Adjustment disorders occur when a person develops
emotional or behavioral symptoms in response to a stressful event
or situation. Symptoms differ from normal bereavement and
typically resolve within 6 months after the stressor's end.
Explanation: Adjustment disorders highlight the challenge some
individuals face in adapting to stressors. Symptoms can include
anxiety, sadness, and difficulty functioning. Recognizing and
